The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients

Cheng He(Ministry of Natural Resources), Chen Liu(Shanghai Medical College of Fudan University), Guopei Luo(Fudan University Shanghai Cancer Center), Jin Xu(Shanghai Medical College of Fudan University), Lu Yu(Shanghai Medical College of Fudan University), Xianjun Yu(Hubei University of Medicine), Liang Liu(Shanghai Medical College of Fudan University), Jiang Long(Shanghai Medical College of Fudan University), Kaizhou Jin(Shanghai Medical College of Fudan University), Meng Guo(Northwest A&F University)
Pancreatology
September 17, 2016
Cited by 65


Related Papers